|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/47 | (2006.01) |
| A61K 47/20 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/42 | (2017.01) |
| (11) | Number of the document | 2687202 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13166031.8 |
| Date of filing the European patent application | 2010-07-28 | |
| (97) | Date of publication of the European application | 2014-01-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-10 |
| (46) | Date of publication of the claims translation | 2023-07-10 |
| (30) | Number | Date | Country code |
| 09167025 | 2009-07-31 | EP |
| (72) |
Adler, Michael , DE
Grauschopf, Ulla , CH
Mahler, Hanns-Christian , DE
Stauch, Oliver Boris , DE
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Poodinė anti-HER2 antikūno vaistinė forma |
| Subcutaneous anti-her2 antibody formulation |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 16 | 347.00 EUR |
| 2026-07-28 |